---
title: "ZYPEEK: Wang Xiuyun reduced holdings by 1.9825% in the past 9 months"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/256509584.md"
description: "ZYPEEK announced that from December 2, 2024, to September 8, 2025, shareholders Wang Xiuyun and Liu Guoliang cumulatively reduced their holdings in the company by 2.4123 million shares, accounting for 1.9825% of the company's total share capital; after the reduction, Wang Xiuyun holds 3.279 million shares, accounting for 2.6948%, Liu Guoliang holds 2.805 million shares, accounting for 2.3053%, and the two together hold 6.084 million shares, accounting for 5.0000%"
datetime: "2025-09-09T08:17:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/256509584.md)
  - [en](https://longbridge.com/en/news/256509584.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/256509584.md)
---

# ZYPEEK: Wang Xiuyun reduced holdings by 1.9825% in the past 9 months

ZYPEEK announced that from December 2, 2024, to September 8, 2025, shareholders Wang Xiuyun and Liu Guoliang cumulatively reduced their holdings in the company by 2.4123 million shares through centralized bidding, accounting for 1.9825% of the company's total share capital; after the reduction, Wang Xiuyun holds 3.279 million shares, accounting for 2.6948%, Liu Guoliang holds 2.805 million shares, accounting for 2.3053%, and the two together hold 6.084 million shares, accounting for 5.0000%

### Related Stocks

- [688716.CN](https://longbridge.com/en/quote/688716.CN.md)

## Related News & Research

- [BYD is struggling to meet demand for new fast-charging EVs as orders reach 100K, 60K](https://longbridge.com/en/news/287109883.md)
- [Europe-China spacecraft launches to study Earth's 'invisible armour'](https://longbridge.com/en/news/286881963.md)
- [Apple Flavor to Buy NovoSana’s China Assets for Up to USD66 Million in Health Supplements Push](https://longbridge.com/en/news/287039106.md)
- [20:00 ETAccro Bioscience Announces $50 Million Series C Financing Led by OrbiMed to Advance Clinical Pipeline for Immune Mediated Diseases](https://longbridge.com/en/news/286830151.md)
- [Assessing NP3 Fastigheter (OM:NP3) Valuation After AGM Dividend Decisions And Board Changes](https://longbridge.com/en/news/286863209.md)